Compound | R | Cytotoxicity (MDL50 in μM) | Toxicity ratios (MDL50) PQ-TZ/PQ | ||
---|---|---|---|---|---|
HepG2 | BGM | HepG2 | BGM | ||
4b | 2-F | NT | NT | – | – |
4c | 3-F | 1302 ± 1 08 | 550 ± 43 | 4.4 | 2.7 |
4d | 4-F | ≥6831 | ≥6831 | 23.3 | 33.8 |
4e | 2-Cl | ≥2193 | ≥2193 | 9.4 | 10.8 |
4f | 3-Cl | 641 ± 31 | 252 ± 24 | 2.7 | 1.2 |
4g | 4-Cl | 3984 ± 116 | NT | 17 | – |
4h | 2-NO2 | 1463 ± 1 05 | 1312 ± 145 | 6.3 | 6.5 |
4i | 3-NO2 | 536 ± 17 | 523 ± 210 | 2.3 | 2.6 |
4j | 4-NO2 | ≥6651 | ≥6651 | 28.5 | 32.9 |
4k | 2-OCH3 | ≥6833 | ≥6833 | 29.3 | 33.8 |
4l | 3-OCH3 | ≥6651 | ≥6651 | 28.5 | 32.9 |
4m | 4-OCH3 | ≥6644 | ≥6644 | 28.5 | 32.9 |
4n | 3-CN | ≥2242 | ≥2242 | 9.6 | 11.0 |
4o | 4-CN | ≥6726 | ≥6726 | 28.8 | 33.3 |
4p | 4-CH3 | ≥6651 | ≥6651 | 28.5 | 32.9 |
Primaquine | 233 ± 5 | 202 ± 35 | – | – |